EUVIMEDEUVIMED entdecken
Crossref

Whole blood derived and apheresis platelets: Opinions and preferences—the results of a national survey of blood collectors

Mark H Yazer iD, Anna Razatos iD, Merlyn Sayers iD

Transfusion · 2023

DOI: 10.1111/trf.17348 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transfusion, 2023. Verfasst von Mark H Yazer und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Blood Platelets, Blood Component Removal. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 5 Literaturangaben. Gefördert von: Terumo BCT.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Currently greater than 94% of the US platelet supply is collected by apheresis. A survey to determine the attitudes of members of America's Blood Centers (ABC) toward whole blood derived (WBD) platelets was designed in light of current platelet supply issues.

Methods

An on‐line survey was distributed to medical directors of the 47 ABC members.

Results

Responses were received from 44/47 (94%) ABC members. There were 15/43 (35%) centers that are currently providing WBD platelets. Seventy percent of the respondents agreed or agreed strongly that WBD and apheresis platelets were clinically equivalent, with approximately 16% indicating that they did not have an opinion on their equivalency and 14% indicating that they were not clinically equivalent. Forty‐four percent of respondents felt that their customers would agree or strongly agree that these products are clinically equivalent, while 26% felt that their customers did not know or were neutral on clinical equivalency. The main barrier to WBD platelet implementation was logistic/inventory management issues, followed by bacterial contamination risk mitigation. There were 21/43 (49%) respondents who indicated they are not considering producing WBD platelets to mitigate shortages. Respondents indicated they might begin producing WBD platelets if there was evidence of increasing customer demand, increased reimbursement, inability to supply apheresis platelets, if pathogen reduction became available for WBD platelets, if the platelet shortage worsened.

Conclusions

The majority of blood collectors consider WBD platelets clinically equivalent to apheresis, however wider adoption of WBD platelets is still hindered by challenges with logistics and inventory management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood PlateletsBlood Component RemovalHumansPlatelet TransfusionBlood PreservationAttitude

Autor:innen und Institutionen

  • Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Terumo BCT, Lakewood, Colorado, USA.
  • Carter BloodCare, Bedford, Texas, USA.
  • University of Texas Southwestern Medical Center, Dallas, Texas, USA.

ORCID-Profile: Mark H Yazer, Anna Razatos, Merlyn Sayers

Förderung

  • Terumo BCT

Zitieren

APA

Yazer, M. H., Razatos, A., & Sayers, M. (2023). Whole blood derived and apheresis platelets: Opinions and preferences—the results of a national survey of blood collectors. Transfusion. https://doi.org/10.1111/trf.17348

Vancouver

Yazer MH, Razatos A, Sayers M. Whole blood derived and apheresis platelets: Opinions and preferences—the results of a national survey of blood collectors. Transfusion. 2023. doi:10.1111/trf.17348

BibTeX
@article{Yazer2023,
  author = {Yazer, Mark H and Razatos, Anna and Sayers, Merlyn},
  title = {Whole blood derived and apheresis platelets: Opinions and preferences—the results of a national survey of blood collectors},
  journal = {Transfusion},
  year = {2023},
  doi = {10.1111/trf.17348}
}
Kostenlos starten →